Muscle phosphoglycerate mutase deficiency revisited

Ali Naini, Antonio Toscano, Olimpia Musumeci, John Vissing, Hasan O. Akman, Salvatore DiMauro

Research output: Contribution to journalArticlepeer-review


Background: Phosphoglycerate mutase (PGAM) deficiency (glycogen storage disease type X) has been reported in 12 patients of whom 9 were African American. Objective: To describe 2 patients, 1 of Pakistani and 1 of Italian ethnic origin, with typical clinical and biochemical changes of glycogen storage disease type X and novel mutations in the gene encoding the muscle subunit of PGAM (PGAM2). Design: Clinical, pathological, biochemical, and molecular analyses. Setting: Tertiary care university hospitals and academic institutions. Patients: A 37-year-old Danish man of Pakistani origin who had exercise-related cramps and myoglobinuria and a 65-year-old Italian man who had exercise intolerance and myalgia but no pigmenturia and had undergone long-term statin therapy. Main Outcome Measures: Clinical course and biochemical and molecular features. Results: Biochemical evidence showed severe isolated PGAM deficiency, and molecular studies revealed 2 novel homozygous mutations, a nonsense mutation and a single nucleotide deletion. Pathological studies of muscle showed mild glycogen accumulation but prominent tubular aggregates in both patients. Conclusions: We found that glycogen storage disease type X is not confined to the African American population, is often associated with sarcoplasmic reticulum (SR) proliferation, and is genetically heterogeneous.

Original languageEnglish
Pages (from-to)394-398
Number of pages5
JournalArchives of Neurology
Issue number3
Publication statusPublished - Mar 2009

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Muscle phosphoglycerate mutase deficiency revisited'. Together they form a unique fingerprint.

Cite this